BCRX
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) [ST]
www.biocryst.com ↗▲ 1.05%
prev close
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Congressional Trades
3
All tracked trades
Members Trading
2
Unique members
Net Activity
+1
2 buys · 1 sells
Members Who Traded This Stock
3 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-11-13 | BCRXBioCryst Pharmaceuticals, Inc. - Common Stock | Buy | $1,001 - $15,000 | 124d ago | — | |
| 2023-10-16 | BCRXBioCryst Pharmaceuticals, Inc. - Common Stock | Buy | $1,001 - $15,000 | 889d ago | — | |
| 2023-09-15 | BCRXBioCryst Pharmaceuticals, Inc. - Common Stock | Sell | $1,001 - $15,000 | 916d ago | — |
2025-11-13
Gilbert Cisneros
BCRX
Amount
$1,001 - $15,000
Filed
124d ago
2023-10-16
Josh Gottheimer
BCRX
Amount
$1,001 - $15,000
Filed
889d ago
2023-09-15
Josh Gottheimer
BCRX
Amount
$1,001 - $15,000
Filed
916d ago
Recent News
Powered by Polygon.io
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2025-11-13 · Purchase
$1,001 - $15,000
Josh Gottheimer
2023-10-16 · Purchase
$1,001 - $15,000
Josh Gottheimer
2023-09-15 · Sale
$1,001 - $15,000